Alnylam Pharmaceuticals, Inc. (ALNY)

Today's Latest Price: $166.36 USD

1.29 (0.78%)

Updated Jan 15 4:00pm

Add ALNY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 483 in Biotech

See all "A" rated Strong Buy stocks

Alnylam Pharmaceuticals Inc (ALNY) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ALNY.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
23 $225 $90 $164.13 $165.07 -0.57%

ALNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.52 6 10 7 0 0 NA

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The number of analysts covering the stock of ALNY is higher than 95.88% of all US stocks.
  • ALNY has a higher average analyst price target than 96.04% of Pharmaceutical Products stocks.
  • Alnylam Pharmaceuticals Inc's variance in analysts' estimates is lower than 10.12% of all US stocks.
  • ALNY has a higher upside potential (average analyst target price relative to current price) than 15.09% of Pharmaceutical Products stocks.
  • Alnylam Pharmaceuticals Inc's percent of analysts bearish on the stock is lower than almost 100% of all US stocks.
  • The percentage of analysts bullish on the stock of ALNY is higher than practically none of all US stocks.
  • ALNY has a less change in bullishness amongst analysts than almost 100% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Alnylam Pharmaceuticals Inc are SRPT, BMRN and RARE.

Make investment decisions regarding ALNY using the data that counts. Try POWR Ratings for free.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6167 seconds.